BGI Genomics Co., Ltd. (SHE:300676)
40.83
+1.58 (4.03%)
Apr 8, 2026, 12:24 PM CST
BGI Genomics Market Cap
BGI Genomics has a market cap or net worth of 15.07 billion as of April 7, 2026. Its market cap has decreased by -37.19% in one year.
Market Cap
15.07B
Enterprise Value
12.17B
Revenue
3.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
40.83
Market Cap Chart
Since July 14, 2017, BGI Genomics's market cap has increased from 7.86B to 15.07B, an increase of 91.73%. That is a compound annual growth rate of 7.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 15.07B | -13.47% |
| Dec 31, 2025 | 17.41B | 8.78% |
| Dec 31, 2024 | 16.01B | -18.66% |
| Dec 29, 2023 | 19.68B | -7.14% |
| Dec 30, 2022 | 21.19B | -41.13% |
| Dec 31, 2021 | 35.99B | -29.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Tigermed Consulting | 45.18B |
| Joinn Laboratories(China)Co.,Ltd. | 24.28B |
| Guangzhou Kingmed Diagnostics Group | 12.04B |
| Dian Diagnostics Group | 11.25B |
| Amoy Diagnostics | 8.73B |
| Cowealth Medical China | 8.32B |
| Shanghai Runda Medical Technology | 7.46B |
| Beijing Strong Biotechnologies,Inc. | 6.93B |